HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Webinars / Adaptive, Umbrella and Basket Studies – What Are They, Why Are They Needed, and How Will Payers Receive Them?

Adaptive, Umbrella and Basket Studies – What Are They, Why Are They Needed, and How Will Payers Receive Them?

Event Date: Jun 04, 2018

As costs continue to rise and downward reimbursement price pressure increases, the industry is exploring new drug development approaches, including innovative randomized controlled trial designs such as adaptive, umbrella, and basket studies.

Adaptive trials, the most established of these, have already been the subject of guidance documents by both the European Medicines Agency (EMA) and Food and Drug Administration (FDA).

Further, in 2017 the FDA provided its first site-agnostic approval of a drug (pembrolizumab) based on data from a basket trial. However, in many markets it is the reimbursement hurdle, rather than the regulatory hurdle, that is proving the major barrier to overcome in order to enable patient access.

Therefore, payer perceptions on such innovative trial designs will be key to informing pharmaceutical company utilization of such approaches.

This webinar will cover:

  • The different innovative approaches and the opportunities that these offer for the development of new medicines.
  • How to conduct price and reimbursement assessments on drugs utilizing these new clinical trial designs from a German and United Kingdom reimbursement perspective, respectively.

Click here for additional information and registration details.



You might also be interested in:

  • Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020
  • New Program in Pharmaceutical Value Assessment and… 01/22/2021
  • Key Innovations Coming From The Next Generation of PBM’s 08/12/2020
  • Matthew McHugh Appointed Director for Health Outcomes and… 02/10/2021
  • Scientist.com Reveals Expanded HEOR, Value, and RWE Category,… 03/23/2021
  • Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
  • Stanford Center for Health Education Launches Online Program… 08/11/2020

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters

Syndicated Reports

Artificial Intelligence in Healthcare Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography

Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry

Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights

Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

White Papers

What to Look for in an Informatics Platform for Life Sciences R&D

Beyond The Field: Evolving Field Medical Engagement And Talent For The Future

Innovating the Delivery of Patient Support: Branded Patient Support programs for Today’s Health Consumer

Healthcare Cost Containment: Best Practices & Recommendations

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute